VasenHFABülowSAnd The Leeds Castle Polyposis Group: Guidelines for thesurveillance and management of familial adenomatous polyposis (FAP): A world wide survey among 41 registries. Colorectal Dis1999;1:214–221.
2.
BülowCVasenHJärvinenHBjörkJBisgaardMLBülowSIleorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis. Gastroenterol2000;119:1454–1460.
3.
VasenHFAvan BallegooijenMBuskensEKleibeukerJKTaalBGGriffioenGNagengastFMMenkoFHKhanMeeraA cost-effectiveness analysis of colorectal screening of hereditary nonpolyposis colorectal carcinoma gene carriers. Cancer1998;82:1632–1637.
4.
LindgrenGLiljegrenAJaramilloERubioCLindholmAAdenoma prevalence and cancer risk in familial non-pyloposis colorectal cancer. GUT2002;50:228–234.
5.
JärvinenHJAarnioMMustonenHAktan-CollanKAaltonenLAPeltomäkiPDe La ChapelleAMecklinJ-PControlled 15-Year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterol2000;118:829–834.
6.
KronborgOColonic screening and surveillance. In: Premalignant conditions of the GI tract: Possibilities for prevention, (ed. AxonA). Best Practice Res Clin Gastroenterol2001; 15: 301–316.
7.
St. JohnDJMcDermottFTHopperJLDebneyEAJohnsonWRHughesESRCancer risk in relatives of patients with common colorectal cancer. Ann Intern Med1993;118:785–790.
8.
FuchsCSGiovanucciELColditzGAA prospective study of family history and the risk of colorectal cancer. In SchmniegelWSchölmerichJ (eds.) Colorectal Cancer. Falk Symposium 109, pp 144–54. Dordrecht: Klüwer1998.
9.
WinawerSJSt. JohnDJBondJHRozenPBurtRWWayeJDKronborgOO'BrienMJBishopDTKurtzRCShikeMSwaroopSVLevinBFruhmorgenPLynchHTPrevention of colorectal cancer: Guidelines based on new data. Bulletin of the WHO1995;73:7–10.
10.
WinawerSJZauberAGGerdesHO'BrienMJGottliebLSSternbergSSBondJHWayeJDSchapiroMPanishJFKurtzRCShikeMAckroydFWStewartETSkolnickMBishopDTAnd the National Polyp Study Workgroup: Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med1996; 334: 82–87.
11.
KjeldsenBJEvaluation of long-term follow-up in patients having had surgery for colorectal cancer with curative intent. PhD thesis Faculty of Health Science, Odense University Denmark, 1998.
12.
JefferyGMHickeyBEHiderPFollow-up strategies for patients treated for non-metastatic colorectal cancer. Update Software Ltd The Cochrane Library 2002 Issue 1.
13.
ShitohKKonishiFMiyakuraYTogashiKOkamotoTNagaiHMikrosatellite instability as a marker in predicting metachronous multiple colorectal carcinomas after surgery. Dis Colon Rectum2002;45:329–333.
14.
RenehanAGEggerMSaundersMPO'DwyerSTThe impact on survival of intensive follow-up after curative resection for colorectal cancer: A meta-analysis of randomised trials. BMJ2002;324:813.
15.
EideTJNatural history of adenomas. World J Surgery1991;15:3–6.
16.
CitardaFTomaselliGCapocacciaRBarcheriniSCrespiMThe Italian Multicentre Study Group: Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. GUT2001; 48: 812–815.
17.
WinawerSJZauberAGHoMNO'BrienMJGottliebLSSternbergSSWayeJDSchapiroMBondJHPanishJFAckroydFShikeMKurtzRCHornsby-LewisLGerdesHStewartETAnd the National Polyp Study Workgroup: Prevention of colorectal cancer by colonoscopic polypectomy. New Engl J Med1993;329:1977–1981.
18.
NuskoGMansmannUKirschnerThHahnEGRisk related surveillance following colorectal polypectomy. Gut2002;51:424–428.
19.
KronborgOFengerCRandomised study of advantages and drawbacks of long-term colorectal adenoma surveillance. Abstract for Tripartite Colorectal Meeting Melbourne, 2002.
20.
WilsonLSLightwoodJModel of estimated rates of colorectal cancer from polyp growth by year of surveillance. J Med Screen2001;8:187–196.
21.
JørgensenODKronborgOFengerCThe Funen adenoma follow-up study. Incidence and death of colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol1993; 28: 869–974.
22.
ProvenzaleDKawdleyKVAroraSWrangJBProphylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterol1995;109:1188–1196.
23.
EadenJAbramsKEkbomAJacksonEMayberryJColorectal cancer prevention in ulcerative colitis: A case-control study. Aliment Pharmacol Ther2000;14:145–153.
24.
SteeleRJCParkerRPatnickJWarnerJFraserCMowatNAGWilsonJAlexanderFEPatersonJGFor the United Kingdom Colorectal Screening Pilot Group: A demonstration pilot trial for colorectal cancer screening in the United Kingdom: A new concept in the introduction of healthcare strategies. J Med Screen2001; 8: 197–203.
25.
KronborgOScreening for colorectal cancer in the *average-risk population. Seminars in Colon Rect Surg2002;13:16–30.
26.
JørgensenODKronborgOFengerCA randomised study for colorectal cancer with faecal occult blood test. Results after 13 years and 7 biennial screening rounds. GUT2002; 50: 29–32.
27.
ScholefieldJHMossSManghamCMHardcastleEffect of faecal occult blood screening on mortality from colorectal cancer: Results from a randomised controlled trial. GUT2002;50:840–844.
28.
NakamaHZhangBZhangXEvaluation of the optimum cut-off point in immunochemical occult blood testing in screening for colorectal cancer. Eur J Cancer2001;37:398–401.
29.
Gyrd-HansenDThe relative economics of screening for colorectal cancer, breast cancer and cervical cancer. Institute of Public Health, University of Southern Denmark, Odense University. Oncol/Hematol1999; 32: 133–144.
30.
AtkinWSEdwardsRWardleJNorthoverJMASuttonSHartARWilliamsCBCusickJDesign of a multicentre randomised trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen2001;8:137–144.
31.
MossSMHardcastleJDColemanDARobinsonMHERodriquesVCInterval cancers in a randomised controlled trial of screening for colorectal cancer using a faecal occult blood test. Int J Epidemiol1999;28:386–390.
32.
McCallionKMitchellRMSWilsonRHKeeFWatsonRGPCollinsJSAGardinerKRFlexible sigmoidoscopy and the changing distribution of colorectal cancer: Implications for screening. Gut2001; 48: 522–525.
33.
LiebermannDAWeissDFor The Veterans Affairs Cooperative Study Group: One-Time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med2001; 345: 555–560.
34.
LiebermanDAWeissDGBondJHAhnenDJGarewalHChejfecGFor Veteran affairs kooperative group 380: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med2000; 343: 162–168.
35.
RexDKLehmanGAHawesRHUlbrightTMSmithJJScreening colonoscopy in asymptomatic average-risk persons with negative fecal occult blood tests. Gastroenterol1991;100:64–67.
36.
WinawerSJFletcherRHMillerLGodleeFStolarMHMulrowCDWoolfSHGlickSNGaniatsTGBondJHRosenLZapkaJGOlsenSJGiardielloFMSiskJEvan AntwerpRBrown-DavisCMarciniakDAMayerRJColorectal cancer screening: Clinical guidelines and rationale. Gastroenterol1997;112:594–642.
37.
FletcherJGLuboldtWCT colonography and MR colonography: Current status, research directions and comparison. Eur Radiol2000;10:786–801.
38.
KronborgOUgstadMFuglerudPJohneBHardcastleJScholefieldJHVellacottKMoshakisVReynoldsJRFaecal calprotectin levels in a high-risk population for colorectal neoplasia. Gut2000;46:795–800.
39.
DaviesRJFreemanAMorrisLSBinghamSDilworthSScottILaskeyRAMillerRColemanNAnalysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet2002;359:1917–1919.
40.
TraversoGShuberALevinBJohnsonCOlssonLSchoetzJHamiltonSRBoyntonKKinzlerKWVogelsteinBDetection of APCmutations in fecal DNA from patients with colorectal tumors. N Engl J Med2002;346:311–320.
41.
Recommendations on cancer screening in the European Union: Advisory Committee on Cancer Prevention. Eur J Cancer2000; 36: 1473–1478.